NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ (CM) NASDAQ (CM) Primary Summary
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RWM Revisor Wealth Management LLC Revisor Wealth Management LLC | 3,269.86 | $15,204.85 | $6,703.21 | -$8,501.64 | -55.91% |
 William Jollie Quent Capital LLC | 6.68 | $35.53 | $14.7 | -$20.83 | -58.63% |
| AK Alisha Kamadia United Community Bank | 3,340 | $15,160.26 | $6,997.3 | -$8,162.96 | -53.84% |
NeuroOne Medical Technologies Corporation (NMTC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NeuroOne Medical Technologies Corporation ever had a stock split?
NeuroOne Medical Technologies Corporation Profile
| Health Care Technology Industry | Healthcare Sector | David A. Rosa CEO | NASDAQ (CM) Exchange | 64130M308 CUSIP |
| US Country | 18 Employees | - Last Dividend | 16 Apr 2026 Last Split | 18 Sep 2017 IPO Date |
Overview
NeuroOne Medical Technologies Corporation, based in Eden Prairie, Minnesota, is a pioneering medical technology company established in 2009. The organization is dedicated to the innovation and commercialization of advanced thin film electrode technology, primarily serving the needs of patients suffering from neurological disorders. These disorders include epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries, among others. To enhance treatment options and patient outcomes, NeuroOne has entered into a strategic partnership with RBC Medical Innovations, focusing on the development of a radio frequency ablation generator. This collaboration underscores the company's commitment to advancing neurological care through innovative solutions.
Products and Services
NeuroOne Medical Technologies Corporation offers a range of products and services designed to meet the diverse needs of patients with neurological conditions:
- Continuous Electroencephalogram (cEEG) Recording Technology: This technology aids in the continuous monitoring of electrical activity in the brain. It is crucial for diagnosing and managing conditions such as epilepsy, enabling precise detection and treatment of abnormal brain activity.
- Stereoelectroencephalography (sEEG) Recording Technology: sEEG is an invasive procedure that measures electrical activity in deeper areas of the brain. This is particularly useful for surgical planning in patients with epilepsy, helping to pinpoint the areas of brain responsible for seizure activity.
- Spinal Cord Stimulation: This therapeutic approach offers relief for chronic pain, especially in cases where other treatments have failed. By delivering mild electrical impulses to the spinal cord, it can significantly reduce pain signals sent to the brain.
- Brain Stimulation: Similar to spinal cord stimulation, this method targets the brain to alleviate symptoms associated with neurological disorders such as Parkinson's disease, dystonia, and essential tremors. It offers a non-pharmacological option for managing these conditions, improving quality of life for many patients.
- Ablation Solutions: Ablation involves the removal of abnormal tissue that causes neurological disorders. NeuroOne is developing technology for precise, targeted ablation, which is less invasive and offers faster recovery times for patients.
